The development of the PPA Progression Planning Aid (PPA-squared) and its clinical application: Improving care for people living with Primary Progressive Aphasia
Saturday, June 14, 2025 |
2:30 PM - 2:40 PM |
Overview
Details
⏲️ 2.30pm - 3.30pm
⌛60-minutes
📚 Assumed knowledge of attendees: Intermediate (Some previous learning/working knowledge of topic e.g. treated a few cases)
Presenter
The development of the PPA Progression Planning Aid (PPA-squared) and its clinical application: Improving care for people living with Primary Progressive Aphasia
2:30 PM - 3:30 PMPresentation summary
For SPs, these syndromes pose unique clinical challenges. The types and timing of intervention programs and advanced care planning are best done when clear information about potential disease / disability progression is known [3]. Recently developed by a UK/Australian collaboration, the PPA Progression Planning Aid (PPA-squared) addresses these knowledge gaps [2]. It provides a prototypical progression and severity scale of functional impairment, informed by the lived experience of caregivers of people with svPPA and nfavPPA.
1. Using E4BP principles, we will describe existing clinical tools {4,5,6}, the research base for symptom staging and the PPA-Squared tool [2].
2. Following this, clinical application will be described using five case studies. Case studies will describe the lived experience of people with PPA and their families and the benefits gained from working with SP and the PPA-Squared.
3. In a group task, attendees will be provided with the unique experience of interacting with the research survey completed by UK and Australian caregivers [2], using a case from their own practice or a generic anonymised case provided by the session presenters.
The fireside chat is an opportunity for attendees to collaboratively engage with experts about the art and science of presenting symptom staging information to individuals living with complex progressive aphasia. The innovative PPA-Squared is a new resource for clinicians practicing in this emerging and expanding area of SP practice.
Refrences
1. Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006-1014. doi:10.1212/WNL.0b013e31821103e6
2. Hardy CJD, Taylor-Rubin C, Taylor B, Harding E, Suarez-Gonzalez A, Jiang J, Thompson L, Kingma R, Chokesuwattanaskul A, Walker F, Barker S, Brotherhood E, Waddington, Wood O, Zimmerman N, Jupelli N, Yong KXX, Camic PM, Stott J, Marshall CR, Oxtoby NP, Rohrer JD, Volkmer A, Crutch SJ, Warren JD. Symptom-led staging for semantic and non-fluent agrammatic variants of primary progressive aphasia. Alzheimer’s & Dementia.2024; 20(1): 419-430 doi: 10.1002/alz.13415
3. Taylor-Rubin C, Croot K, Nickels L. Speech and language therapy in primary progressive aphasia: a critical review of current practice. Expert review of Neurotherapeutics. 2021;24(4): 195-210 doi:10.1080/14737175.2021.1897253
4. Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139(9):1136-1139. doi:10.1176/ajp.139.9.1136
5. Mioshi E, Hsieh S, Savage S, Hornberger M, Hodges JR. Clinical staging and disease progression in frontotemporal dementia. Neurology. 2010;74(20):1591-1597. doi:10.1212/WNL.0b013e3181e04070
6. Sapolsky D, Domoto-Reilly K, Dickerson BC. Use of the Progressive Aphasia Severity Scale (PASS) in monitoring speech and language status in PPA. Aphasiology. 2014;28(8-9):993-1003. doi:10.1080/02687038.2014.931563
**********
The development of the PPA Progression Planning Aid (PPA-squared) and its clinical application: Improving care for people living with Primary Progressive Aphasia
2:30 PM - 3:30 PM**********
The information contained in this program is current at of the time of publishing but is subject to changes made without notice.
Disclaimer: © (2024) The Speech Pathology Association of Australia Limited. All rights reserved.
Important Notice, please read: The views expressed in this presentation and reproduced in these materials are not necessarily the views of, or endorsed by, The Speech Pathology Association of Australia Limited ("the Association"). The Association makes no warranty or representation in relation to the content, currency or accuracy of any of the materials comprised in this presentation. The Association expressly disclaims any and all liability (including liability for negligence) in respect of use of these materials and the information contained within them. The Association recommends you seek independent professional advice prior to making any decision involving matters outlined in this presentation including in any of the materials referred to or otherwise incorporated into this presentation.
.
